According to relevant public information, as of February 1 day, 2023, the market share of Fosun Pharma was 4.7%, among which the amoxicillin capsule market accounted for the largest proportion.
Fosun Pharma insists on patient-centered and clinical demand-oriented, and has invested heavily in innovative research and development of new drugs, and built a multi-level and key technology platform including bio-similar drugs, small molecule innovative drugs, high-value generic drugs and new technology treatments. It is the leader of original research and innovation in China.